跳至主要内容
临床试验/JPRN-jRCT1040210116
JPRN-jRCT1040210116进行中(未招募)未知

Retrospective multicenter clinical study of risk factors for cetuximab-related infusion reaction in Japanese patients

Onoda Chiharu0 个研究点目标入组 244 人开始时间: 2021年12月25日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
244

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Over 20 years old,Japanese, the first administration of cetuximab with chemotherapy or alone

排除标准

  • The patients who have allergic reaction during chemotherapy administration on the same day

研究者

发起方
Onoda Chiharu

相似试验

已完成
不适用
Retrospective multicenter analysis of risk factors, microbial spectrum, resistance development, therapy, and effectiveness of prophylactic medication of Spontaneous Bacterial PeritonitisK65.0Acute peritonitis
DRKS00017728Klinikum rechts der Isar, TU München1,814
招募中
不适用
The multicenter prospective study for risk factor and clinical meaning of spinal sagittal imbalance in KoreaDiseases of the musculo-skeletal system and connective tissue
KCT0002065Yonsei University Health System, Severance Hospital200
已完成
不适用
A multicenter prospective study of risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in cancer patients receiving intravenous bisphosphonate or denosumab therapyCancer patients receiving high-dose bone-modifying agents who tooth extraction were performed
JPRN-UMIN000033743Kobe University Graduate School of Medicine30
已完成
不适用
Prospective multi-center study of health risks after acute ingestion of cleaning and cosmetic products containing surfactantT55J69Toxic effect of soaps and detergentsPneumonitis due to solids and liquids
DRKS00000702Vergiftungs-Informations-ZentraleZentrum für Kinder- und JugendmedizinUniversitätsklinikum Freiburg605
进行中(未招募)
不适用
A retrospective multi-centre clinical study of a deep learning system in identifying breast cancer through the assessment of mammogramsDecision support in breast cancer screeningCancer
ISRCTN15504688Kheiron Medical Technologies (United Kingdom)1,000,000